Clinical Trials in Illinois

Showing 8681-8700 of 19,692 trials

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

NCT00079417

This phase III trial is studying how well giving carboplatin and vincristine together with standard local ophthalmic therapy works in treating children with intraocular retinoblastoma. Drugs used in chemotherapy, such as carboplatin and vincristine, work in different ways to stop tumor from dividing so they stop growing or die. It is not yet known whether neoadjuvant chemotherapy combined with standard local ophthalmic therapy is effective in treating intraocular retinoblastoma.

Intraocular Retinoblastoma

Children's Oncology Group28 participantsStarted Dec 2005

Los Angeles, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +7 more locations

COMPLETEDPhase 3125 miles

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

NCT03503318

The purpose of the study is to evaluate the efficacy, safety, and tolerability of different dose regimens of TV-46000 administered subcutaneously (SC) as compared to placebo during maintenance treatment in adult and adolescent participants with schizophrenia. The study will include male and female participants, 13 to 65 years of age, who have a confirmed diagnosis of schizophrenia, are clinically stable, and are eligible for risperidone treatment

Schizophrenia

Teva Branded Pharmaceutical Products R&D, Inc.544 participantsStarted Apr 2018

Little Rock, Arkansas, United States • Rogers, Arkansas, United States • Anaheim, California, United States +78 more locations

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Find Trials by Condition in Illinois

Tele-Coaching Intervention to Improve Treatment Adherence in Cystic Fibrosis

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

A Safety Study of SGN-LIV1A in Breast Cancer Patients

An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Integrated Second Language Learning for Chronic Care

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

Achieving Diagnostic Excellence Through Prevention and Teamwork

A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients